Trial intelligence / Profile preview

Topicort Spray in Scalp Psoriasis

NCT02985736Phase 4Completed

Sponsor
Psoriasis Treatment Center of Central New Jersey
Start
Sep 2016
Primary completion
Jan 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of desoximetasone in psoriasis, sponsored by Psoriasis Treatment Center of Central New Jersey. Primary endpoint: Investigator Global Assessment (Scalp Only) at 16 weeks. Started Sep 2016; status: completed.

02

Drugs

desoximetasone
03

Conditions

psoriasis

Beyond the preview

Go deeper on NCT02985736.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02985736.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call